The promise of proteomics for cancer prevention

Proteomic approaches hold significant promise for cancer prevention by greatly expanding the discovery of biomarkers. Most current drugs act by ...

PROMISE: PROteoMIcS REsearch for Advancements in Prevention ...

The availability of large-scale proteomics in mature prospective cohorts therefore presents key opportunities to advance our understanding of cancer aetiology ...

Proteomic Contributions to Personalized Cancer Care - PMC - NCBI

Proteomics holds great promise in contributing to the prevention and cure of cancer because it provides unique tools for discovery of biomarkers and ...

The promise of omics-based approaches to cancer prevention

The ultimate goal is to apply these high-throughput technologies to the various aspects of clinical cancer care: cancer-risk assessment, diagnosis, as well as ...

Zhe Huang on LinkedIn: The promise of proteomics for cancer ...

The promise of proteomics for cancer prevention - Cancer Research UK - Cancer News · More Relevant Posts · Explore topics · Sign in to view more ...

Proteomics promises a new era of precision cancer medicine - Nature

Whether and how the proteomic profiling data may facilitate the development of precision strategies and/or predictive biomarkers for ...

The promise of proteomics: Transforming healthcare from treatment ...

The promise of proteomics: Transforming healthcare from treatment to disease prevention · Detecting markers for cancer years before diagnosis.

Identifying proteomic risk factors for cancer using prospective and ...

Proteomics holds significant promise for developing future cancer prevention initiatives that are needed to address the predicted increase ...

Pan-cancer proteogenomics expands the landscape of ... - Cell Press

We integrate Clinical Proteomic Tumor Analysis Consortium (CPTAC) proteogenomics data from 1,043 patients across 10 cancer types with additional public datasets ...

Shedding New Light on Cancer Biology - NCI

NCI's Clinical Proteomics Tumor Analysis Consortium is focused on studying whether proteomics data can be used to help improve cancer diagnosis, treatment, and ...

The Promise of Proteomics for the Study of ADP-Ribosylation

The proteomics work in the A.K.L.L. and S.-E.O. Laboratories have been supported by a DOD Breast Cancer Research Program Idea Award #BC101881 (A.K.L.L.), an NIH ...

Proteomics, Personalized Medicine and Cancer - MDPI

An unmet clinical need is the ability to identify patients who do not benefit from highly morbid surgical resection, which is currently the only curative intent ...

Clinical Proteomics: A Promise Becoming Reality

from National Cancer Institute (NCI) Clinical Proteomic Tumor Analysis Consortium program, Swiss National Science Foundation (SNF) grant ...

Clinical Cancer Proteomics: Promises and Pitfalls - ACS Publications

Proteome analysis promises to be valuable for the identification of tissue and serum biomarkers associated with human malignancies.

Advantages of monitoring biotherapies in oncology

neck cancer patients. Sci Rep 2017;7(1):2714. 4. Cosson VF et al ... Ciccolini declares having links of interest with Promise Proteomics,. Pfizer ...

Cancer Proteomics Analysis

Proteomics is a valuable tool for the discovery of biomarkers and therapeutic targets. Thus, it holds great promise for cancer prevention and treatment.

SCIEX to commercialize targeted proteomics technology developed ...

Widely available MRM-based proteomics assays, Paulovich envisions, will transform research by increasing the reproducibility of preclinical ...

Proteomics technologies for cancer liquid biopsies

Alterations in DNAs could not reveal what happened in proteins. The accumulated alterations of DNAs would change the manifestation of ...

The promise of biomarkers in cancer screening and detection

Clinical assays that detect the early events of cancer offer an opportunity to intervene and prevent cancer progression. Biomarkers are important molecular ...

The Promise of Preventive Cancer Vaccines - MDPI

A combination of immunopreventive cancer strategies and recently approved checkpoint inhibitors is a further promise of forthcoming successful cancer disease ...